Company (Country) | Vaccine | Partnership | Stage of development |
---|---|---|---|
Vabiotech (Vietnam) | mORCVAX | IVI re-formulated redeveloped the process to meet WHO standards | Licensed in Vietnam |
Shanat (India) | Shancol | Technology transfer May 2008 | Licensed in India (Feb 2009) |
WHO prequalified Sep 2011 | |||
Eubiologics (Korea) | Euvichol | Technology transfer May 2010–2011 | Korean export license 2014 |
WHO prequalified Dec 2015 | |||
Incepta (Bangladesh) | Cholvax | Technology transfer May 2014 | IVI conducting clinical trial in Bangladesh, license expected in 2017–2018 |